Last update:
Urology news
FDA approves oral Utebzi antibiotic for complicated urinary tract infections
The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).
10 hours ago
0
2
New blood test detects more high-risk prostate cancer cases
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the ...
19 hours ago
0
2
Testosterone therapy labels and limits may change under FDA proposal
The U.S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone replacement therapy products to reflect newer clinical evidence.
13 hours ago
0
3
FDA approves Welireg with pembrolizumab for renal cell carcinoma
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
6
Jeremy Clarkson has aggressive prostate cancer. What makes some cancers more aggressive than others?
UK media celebrity Jeremy Clarkson this week revealed he has been diagnosed with an aggressive form of prostate cancer.
Jun 18, 2026
0
13
Spatial map of bladder cancer reveals hidden tumor environments, new paths toward precision therapy
Researchers at The University of Texas MD Anderson Cancer Center have developed a spatial map of muscle-invasive bladder cancer, revealing how tumor cell states, immune environments and therapeutic vulnerabilities are organized ...
Jun 18, 2026
0
3
Hidden PIM1 pathway helps prostate cancer survive treatment, pointing to new drug strategy
Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.
Jun 16, 2026
0
7
Three men's health drugs that were originally designed for a different purpose
Many medicines begin life with one purpose and end up proving useful for a completely different reason.
Jun 16, 2026
0
4
Experimental treatment directly kills prostate tumor cells while reawakening antitumor immunity
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell ...
Jun 15, 2026
0
12
Clinical trials suggest GLP-1s may improve fertility in men with obesity
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve ...
Jun 15, 2026
0
5
FDA approves combination therapy for higher-risk clear cell kidney cancer after surgery
The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component ...
Jun 15, 2026
0
3
Hard-to-detect prostate cancer may grow through cancer-stroma KRAS signaling
A research team at Kanazawa University, led by Professor Atsushi Mizokami, Associate Professor Koji Izumi and Specially Appointed Assistant Professor Taiki Kamishima (a fourth-year doctoral student at the Graduate School ...
Jun 12, 2026
0
5
Immune biomarkers may predict response to bladder cancer treatment
A Northwestern Medicine study has offered new clues as to why immunotherapy works well for some bladder cancer patients but fails for others, according to a study published in the Journal of Clinical Investigation.
Jun 10, 2026
0
3
First report on the clinical efficacy of chemoimmunotherapy for ultra-rare urachal cancer
Physician-scientists at Kanazawa University have demonstrated, for the first time, the clinical efficacy of chemoimmunotherapy in patients with ultra-rare urachal cancer. Furthermore, their reverse translational research ...
Jun 10, 2026
0
3
Trial to test AI for prostate MRI cancer diagnosis
A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate cancer on MRI scans.
Jun 8, 2026
0
8
Physician experts call for systems-based approach to prostate cancer screening decisions
Prostate cancer screening is one of the most common decisions men face in primary care, yet many patients make that choice without fully understanding the potential benefits and harms. A new editorial by UNC physician experts ...
Jun 4, 2026
0
3
Aspirin may unmask silent bladder cancer by triggering bleeding
The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause mild bleeding or worsen existing bleeding in the urinary tract. ...
Jun 3, 2026
0
15
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows
A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination ...
Jun 2, 2026
0
737
Immunotherapy added to radiation therapy boosts survival in localized prostate cancer
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival ...
Jun 2, 2026
0
27
New practice guidance available for treatment of enlarged prostate
The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery embolization (PAE) to treat enlarged prostate (also called benign prostatic hyperplasia or BPH). The guidance ...
Jun 2, 2026
0
6
New theranostic approach effectively detects and treats neuroendocrine prostate cancer
A novel theranostic approach that targets RET—a newly identified biomarker for neuroendocrine prostate cancer—enables high-contrast PET imaging and effective, safe treatment for this highly aggressive malignancy. Because ...
Jun 2, 2026
0
3
Study of prostate cancer in Brazil reveals racial inequalities in diagnosis and treatment
The largest real-world study ever conducted on prostate cancer in Brazil analyzed data from 670,205 patients treated through the Brazilian Unified Health System (SUS) over a 16-year period, between 2008 and 2023. Published ...
Jun 1, 2026
0
5
Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death
High-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone therapy before and after prostate cancer surgery ...
Jun 1, 2026
0
2
Cannabis use does not lower testosterone, study concludes
The effects of cannabis on the hormonal system and male fertility remain controversial within the scientific community. A study conducted by the University of Geneva (UNIGE), in collaboration with the Swiss Center for Applied ...
May 28, 2026
1
15
Researchers identify new target to prevent aggressive form of prostate cancer
Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease. The study published in the Journal of ...
May 28, 2026
0
6
